Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 2021Cell ReportsOpen Access

Targeting TREM2 on tumor-associated macrophages enhances immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMikhail BinnewiesJPJoshua L. PollackJRJoshua Rudolph

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Binnewies et al. (2021) studied this question.

synapsesocial.com/papers/69ff5585ef8139f8ff7756dahttps://doi.org/10.1016/j.celrep.2021.109844
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes1996 · 1,574 citations
  2. 2Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study2015 · 595 citations
  3. 3Antitumor activity of lurbinectedin (PM01183) and doxorubicin in relapsed small-cell lung cancer: results from a phase I study2017 · 85 citations
  4. 4Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets2019 · 964 citations
  5. 5A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells2021 · 1,677 citations